These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16473356)

  • 21. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 22. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Funding food science and nutrition research: financial conflicts and scientific integrity.
    Rowe S; Alexander N; Clydesdale F; Applebaum R; Atkinson S; Black R; Dwyer J; Hentges E; Higley N; Lefevre M; Lupton J; Miller S; Tancredi D; Weaver C; Woteki C; Wedral E;
    Nutr Rev; 2009 May; 67(5):264-72. PubMed ID: 19386030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug industry and the new recommendations of the Vancouver group].
    Lund H
    Tidsskr Nor Laegeforen; 2001 Oct; 121(24):2851. PubMed ID: 11706496
    [No Abstract]   [Full Text] [Related]  

  • 26. Reporting of clinical trials: publication, authorship, and trial registration.
    Bonita RE; Adams S; Whellan DJ
    Heart Fail Clin; 2011 Oct; 7(4):561-7. PubMed ID: 21925440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lessons learned from the coxibs' ups and downs. The journals must be tougher against referees and authors].
    Milerad J
    Lakartidningen; 2008 May 21-27; 105(21):1560-1. PubMed ID: 18574991
    [No Abstract]   [Full Text] [Related]  

  • 28. Tobacco industry sponsorship of a book and conflict of interest.
    Hong MK; Bero LA
    Addiction; 2006 Aug; 101(8):1202-11. PubMed ID: 16869850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Researchers' statements concerning their economic liaisons].
    Kesek M
    Lakartidningen; 2002 May; 99(19):2191. PubMed ID: 12082940
    [No Abstract]   [Full Text] [Related]  

  • 30. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physicians' participation in clinical drug trials].
    Nielsen OH; Ainsworth M
    Ugeskr Laeger; 2003 Apr; 165(16):1639. PubMed ID: 12756815
    [No Abstract]   [Full Text] [Related]  

  • 32. Worrisome ailment in medicine: misleading journal articles; editors demand more data to ensure full disclosure of drug risks, trial gaps; Sarbanes-Oxley for professors.
    Mathews AW
    Wall St J (East Ed); 2005 May; ():A1, A9. PubMed ID: 15966125
    [No Abstract]   [Full Text] [Related]  

  • 33. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 36. [Independent clinical trials are imperative].
    Gøtzsche PC
    Ugeskr Laeger; 2005 Apr; 167(14):1491-4. PubMed ID: 15887740
    [No Abstract]   [Full Text] [Related]  

  • 37. How pharmaceutical industry funding affects trial outcomes: causal structures and responses.
    Sismondo S
    Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rebuttal: secret ties to industry and conflicting interests in cancer research.
    McLaughlin JK; Boice JD; Tarone RE; Blot WJ
    Am J Ind Med; 2007 Mar; 50(3):235-6. PubMed ID: 17187382
    [No Abstract]   [Full Text] [Related]  

  • 39. [Publishing of scientific studies is no longer dependent on considerations of space in medical journals].
    Eliasson M
    Lakartidningen; 2001 Nov; 98(47):5394. PubMed ID: 11763644
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.